CLINICAL_TRIALS
trial_result
· 2021-08-16
Clinical Trial Update: Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211) [Phase 2]
Summary
Phase 2 open-label extension study assessing safety and tolerability of KNS-760704 in amyotrophic lateral sclerosis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Knopp Biosciences | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2021-08-16